维普中文期刊产品整合服务
14篇 您的检索式:作者名="BLESSINGER J"
    题名 作者 年代 出处 被引量
1High-resolution CCD camera for industrial imaging显示文摘MARTIN G J BLESSINGER K V VEITS C 1901SPIE1901,,:1
2High-resolution CCD camera for industrial imaging显示文摘MARTIN G J BLESSINGER KV VEITS C 1901SPIE1901,,:1
3Walking and running economy:inverse association with peak oxygen uptake显示文摘Sawyer B Blessinger J Irving B 0,,11:1
4Results of the phase III,placebo-controlled trial(SUCCEED)evaluating the mTOR inhibitor ridaforolimus(R)as maintenance therapy in advanced sarcoma patients(pts)fol owing clinical benefit from prior standard cytotoxic chemotherapy(CT)显示文摘Chawla SP Blessing J Ray-Coquard I 0,,:1
5Reliability of the VmaxST portable metabolic measurement system 显示文摘BLESSINGER J SAWYER B DAVIS C 2009Int J Sports Med2009,30,1:1
6Phase III trial of doxorubicin ±cisplatin in advanced or recurrent endometrial carcinoma:A Gynecological Oncology Group (GOG) study显示文摘Thigpen T Blessing J Homesley H 0,,:1
7TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans -Signaling显示文摘Christoph Becker Massimo C. Fantini Christoph Schramm Hans A. Lehr Stefan Wirtz Alexei Nikolaev Jürgen Burg Susanne Strand Ralf Kiesslich Samuel Huber Hiroaki Ito Norihiro Nishimoto Kazuyuki Yoshizaki Tadamitsu Kishimoto Peter R. Galle Manfred Blessing St 2004Immunity2004,,4:1
8Walking and running economy:inverse association with peak oxygen up- take显示文摘SAWYER B J BLESSINGER J R IRVING B A 2010IVied Sei Sports Exe2010,42,11:1
9Adjuvant therapy of ovarian germ cell tumors with cisplatin,etoposide,and bleomycin:a trial of the Gynecologic Oncology Group显示文摘Williams S Blessing J A Liao S Y 0,,04:1
10A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell–mediated liver inflammation显示文摘Jürgen Siebler Stefan Wirtz Sonja Klein Martina Protschka Manfred Blessing Peter R. Galle Markus F. Neurath 2003Hepatology2003,,6:1
11Reliability of the VmaxST portable metabolic measurement system 显示文摘BLESSINGER J SAWYER B DAVIS C 2009Int J Sports Med2009,30,1:1
12Phase Ⅱ clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy with exploratory TS,DPD,and TP correlates:A gynecologic oncology group study显示文摘Carcia AA Blessing JA Lenz H J 0,,03:1
13Phase Ⅱ evaluation of topotecan in carcinosarcoma of the uterus:a Gynecologic Oncology Group study显示文摘Miller DS Blessing JA Schilder J 0,,:1
14Walking and Running Economy:Inverse Association with Peak Oxygen Uptake显示文摘SAWYER B J BLESSINGER B IRVING 0,,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费